SENS · Senseonics Holdings, Inc.

Senseonics Holdings, Inc., a commercial-stage medical technology company, focuses on development and manufacturing of continuous glucose monitoring (CGM) systems for people with diabetes in the United States and internationally. Its products include Eversense, Eversense XL, Eversense E3, and Eversense 365, which are implantable CGM systems to measure glucose levels in people with diabetes through an under-the-skin sensor, a removable and rechargeable smart transmitter, and an app for real-time diabetes monitoring and management. The company serves healthcare providers and patients through a network of distributors and strategic fulfillment partners. Senseonics Holdings, Inc. was founded in 1996 and is headquartered in Germantown, Maryland.

Cap structure and valuation

Cap structure
SP	$8.82
SO	52.9M
Options	1.5M
Warrants	2.4M
FD SO	56.7M
MC	$500.5M

Cash	$44.8M
Total debt	$55.8M
EV	$511.6M

TTM Multiples
EV / Revenue	10.5x
EV / EBITDA	—
MC / Net Income	—
EV / FCF	—
MC / FCF	—

Ownership & coverage
Institutional	39.6%
Insiders	9.8%
# Institutions	147
Analysts	5
Consensus	Buy
Avg target	$13.40

Short % float	12.0%
Days to cover	11.57

MC = SP × FD SO. EV = MC + Debt − Cash. SP = previous yfinance close. Balance-sheet figures as of 2026-07-31. Multiples use TTM (sum of last 4 quarters); shown as "—" when the denominator is zero or negative, or when fewer than four quarters are reported — a partial sum is not a trailing twelve months. Ownership & coverage per Yahoo Finance as of 2026-08-21 — institutional % is 13F-based, so it can lag a quarter and exceed 100% on share-count timing. Short interest per FINRA bi-monthly reporting, as of 2026-07-31; the float denominator can be unreliable on tiny floats.

Financial statements

	6/30/26	3/31/26	12/31/25	9/30/25
Total Revenue	14.48	11.71	14.26	8.10
Revenue YoY %	117.8%	87.2%	71.8%	89.9%
Cost of Revenue	5.92	4.77	6.59	4.63
Gross Profit	8.56	6.94	7.67	3.47
Gross Profit YoY %	174.2%	361.1%	94.1%	185.6%
Gross Margin %	59.1%	59.3%	53.8%	42.8%

SG&A	32.91	30.18	19.77	15.31
R&D	11.64	8.61	8.82	7.76
Operating Expense	44.55	38.79	28.59	23.07

Operating Income	(35.99)	(31.85)	(20.93)	(19.60)
Operating Income YoY %	(151.3%)	(136.1%)	(46.6%)	14.2%
Operating Margin %	(248.5%)	(271.9%)	(146.8%)	(242.1%)
EBITDA	(35.44)	(31.30)	(20.54)	(19.23)
EBITDA Margin %	(244.7%)	(267.3%)	(144.1%)	(237.5%)

Interest Expense	1.60	1.19	1.21	1.17
Other Income / (Expense)	0.88	0.70	1.31	1.24
Pretax Income	(36.70)	(32.33)	(20.82)	(19.53)
Tax Provision	0.00	0.00	0.00	0.00
Net Income	(36.70)	(32.33)	(20.82)	(19.53)
Net Income to Common	(36.70)	(32.33)	(20.81)	(19.53)
Net Margin %	(253.4%)	(276.1%)	(146.1%)	(241.3%)

Diluted EPS	-$0.63	-$0.71	-$0.47	-$0.43
Basic EPS	-$0.63	-$0.71	-$0.47	-$0.43
Diluted Avg Shares	57.8	45.8	—	45.0
Basic Avg Shares	57.8	45.8	—	45.0

	LTM	12/31/25	12/31/24	12/31/23	12/31/22
Total Revenue	48.55	35.26	22.47	22.39	16.39
Revenue YoY %	37.7%	56.9%	0.4%	36.6%	—
Cost of Revenue	21.91	19.49	21.94	19.30	13.66
Gross Profit	26.64	15.76	0.53	3.09	2.73
Gross Profit YoY %	69.0%	2857.4%	(82.8%)	13.4%	—
Gross Margin %	54.9%	44.7%	2.4%	13.8%	16.6%

SG&A	98.17	52.51	34.23	29.94	31.63
R&D	36.83	31.59	41.14	48.75	39.72
Operating Expense	135.00	84.10	75.38	78.69	71.35

Operating Income	(108.36)	(68.34)	(74.84)	(75.60)	(68.63)
Operating Income YoY %	(58.6%)	8.7%	1.0%	(10.2%)	—
Operating Margin %	(223.2%)	(193.8%)	(333.0%)	(337.7%)	(418.7%)
EBITDA	(106.51)	(66.83)	(73.37)	(74.33)	(67.64)
EBITDA Margin %	(219.4%)	(189.5%)	(326.5%)	(332.0%)	(412.7%)

Interest Expense	5.17	4.95	8.44	11.11	18.70
Other Income / (Expense)	4.14	4.17	4.66	26.32	229.45
Pretax Income	(109.39)	(69.11)	(78.62)	(60.39)	142.12
Tax Provision	0.00	0.00	0.00	0.00	0.00
Net Income	(109.39)	(69.11)	(78.62)	(60.39)	142.12
Net Income to Common	(109.38)	(69.10)	(78.60)	(60.40)	142.10
Net Margin %	(225.3%)	(196.0%)	(349.8%)	(269.7%)	867.2%

Diluted EPS	-$2.24	-$1.66	-$0.12	-$0.11	-$0.11
Basic EPS	-$2.24	-$1.66	-$0.12	-$0.11	$0.30
Diluted Avg Shares	57.8	41.7	629.7	568.0	618.2
Basic Avg Shares	57.8	41.7	629.7	568.0	468.0

	6/30/26	3/31/26	12/31/25	9/30/25
Cash & Equivalents	44.75	29.61	40.23	34.46
Short-term Investments	97.91	34.71	53.80	76.49
Receivables	10.27	14.71	12.12	7.20
Inventory	8.46	8.31	6.70	6.32
Other Current Assets	5.07	4.94	4.68	6.80
Total Current Assets	166.46	92.28	117.53	131.28

Operating Lease ROU	5.84	6.05	4.46	4.56
Intangible Assets	—	—	0.60	—
Other Assets	4.54	4.52	3.68	4.09
Total Assets	176.84	102.86	126.27	139.92

Accounts Payable	4.82	3.19	4.06	5.93
Current Lease Liabilities	0.97	0.94	0.50	0.48
Other Current Liabilities	18.88	22.19	19.79	14.66
Total Current Liabilities	24.68	26.32	24.35	21.07
Long-term Debt	55.81	35.91	35.59	35.27
Long-term Lease Liabilities	6.04	6.29	5.29	5.42
Total Liabilities	86.52	68.52	65.22	61.76

Retained Earnings	(1,086.03)	(1,049.32)	(1,016.99)	(996.16)
Total Equity	90.31	34.34	61.05	78.17

	LTM	12/31/25	12/31/24	12/31/23	12/31/22
Cash & Equivalents	44.75	40.23	74.60	75.71	35.79
Short-term Investments	97.91	53.80	0.00	33.75	108.22
Receivables	10.27	12.12	6.29	—	—
Inventory	8.46	6.70	4.42	8.78	7.31
Other Current Assets	5.07	4.68	6.13	11.80	9.88
Total Current Assets	166.46	117.53	91.44	130.03	161.20

Net PPE	—	—	—	1.18	1.11
Operating Lease ROU	5.84	4.46	4.84	5.18	3.03
Intangible Assets	—	0.60	—	—	—
Long-term Investments	—	—	—	—	12.25
Other Assets	4.54	3.68	4.16	1.83	—
Total Assets	176.84	126.27	100.44	138.22	177.67

Accounts Payable	4.82	4.06	3.21	4.57	0.42
Current Lease Liabilities	0.97	0.50	0.43	0.37	0.72
Other Current Liabilities	18.88	19.79	35.22	12.32	30.33
Total Current Liabilities	24.68	24.35	38.85	17.26	31.47
Long-term Debt	55.81	35.59	34.70	41.20	56.38
Long-term Lease Liabilities	6.04	5.29	5.79	6.21	2.69
Other Liabilities	—	—	—	—	52.05
Total Liabilities	86.52	65.22	79.34	64.77	142.59
Mezzanine Equity	—	—	37.66	37.66	37.66

Retained Earnings	(1,086.03)	(1,016.99)	(947.87)	(869.26)	(808.87)
Total Equity	90.31	61.05	(16.55)	35.80	(2.58)

	6/30/26	3/31/26	12/31/25	9/30/25
Net Income	(36.70)	(32.33)	(20.82)	(19.53)
D&A	0.55	0.55	0.38	0.38
Stock-Based Comp	3.57	2.28	2.62	2.79
Δ Working Cap & Other	2.45	(2.51)	(0.15)	0.54
Operating Cash Flow	(30.14)	(32.02)	(17.96)	(15.82)

CapEx	(0.22)	(0.11)	(0.39)	(0.16)
Other Investing	(63.16)	18.11	23.04	19.05
Investing Cash Flow	(63.38)	18.00	22.64	18.89

Stock Issuance	50.00	3.49	—	—
Other Financing	58.66	—	1.10	—
Financing Cash Flow	108.66	3.41	1.10	(0.13)

Free Cash Flow	(30.36)	(32.14)	(18.36)	(15.98)

	LTM	12/31/25	12/31/24	12/31/23	12/31/22
Net Income	(109.39)	(69.11)	(78.62)	(60.39)	142.12
D&A	1.85	1.51	1.48	1.28	0.98
Stock-Based Comp	11.27	10.15	9.22	8.67	8.62
Δ Working Cap & Other	0.33	(1.68)	7.45	(19.72)	(218.03)
Operating Cash Flow	(95.94)	(59.13)	(60.47)	(70.16)	(66.31)

CapEx	(0.89)	(1.12)	(2.24)	(0.35)	(0.31)
Other Investing	(2.96)	(52.31)	35.08	90.06	27.19
Investing Cash Flow	(3.85)	(53.42)	32.84	89.71	26.88

Other Financing	113.03	78.19	26.83	20.37	41.76
Financing Cash Flow	113.03	78.19	26.83	20.37	41.76

Free Cash Flow	(96.83)	(60.24)	(62.70)	(70.51)	(66.62)

	6/30/26	3/31/26	12/31/25	9/30/25
Current Ratio	6.74	3.51	4.83	6.23
Quick Ratio	6.40	3.19	4.55	5.93
Debt / Equity	0.62	1.05	0.58	0.45
EBITDA Margin %	(244.7%)	(267.3%)	(144.1%)	(237.5%)
Working Capital	141.78	65.96	93.19	110.20
Net Debt	11.05	6.30	(4.65)	0.81
ROE %	(40.6%)	(94.2%)	(34.1%)	(25.0%)
ROA %	(20.8%)	(31.4%)	(16.5%)	(14.0%)

	LTM	12/31/25	12/31/24	12/31/23	12/31/22
Current Ratio	6.74	4.83	2.35	7.53	5.12
Quick Ratio	6.40	4.55	2.24	7.03	4.89
Debt / Equity	0.62	0.58	-2.10	1.15	-21.89
EBITDA Margin %	(219.4%)	(189.5%)	(326.5%)	(332.0%)	(412.7%)
Working Capital	141.78	93.19	52.59	112.77	129.73
Net Debt	11.05	(4.65)	(39.89)	(34.51)	20.59
ROE %	(121.1%)	(113.2%)	474.9%	(168.7%)	(5517.0%)
ROA %	(61.9%)	(54.7%)	(78.3%)	(43.7%)	80.0%

Insider activity (last 2 years)

Date Filed	Reporter	Relationship	Trans. Date	Code	Shares	Price	Total Value
2026-08-20	ROEDER DOUGLAS A	Director	2026-08-19	P	13,953	$8.98	$125,300
2026-07-02	Prince Douglas S	Director	2026-07-01	A	1,515	$5.36	$8,120
2026-07-02	ROEDER DOUGLAS A	Director	2026-07-01	A	2,751	$5.36	$14,745
2026-07-02	Fiorentino Edward	Director	2026-07-01	A	2,635	$5.36	$14,124
2026-07-02	Steven Edelman	Director	2026-07-01	A	2,402	$5.36	$12,875
2026-06-17	Kaufman Francine	Director, Officer (Chief Medical Officer)	2026-06-15	F	(4,010)	$7.18	-$28,792
2026-06-17	JAIN Mukul	Officer (Chief Operating Officer)	2026-06-15	F	(16,194)	$7.18	-$116,273
2026-06-17	Sullivan Frederick T.	Officer (Chief Financial Officer)	2026-06-15	F	(5,397)	$7.18	-$38,750
2026-06-17	Horton Kenneth L	Officer (GC & Corp. Development Advisor)	2026-06-15	F	(9,545)	$7.18	-$68,533
2026-06-17	HANSEN BRIAN B	Director, Officer (Chief Commercial Officer)	2026-06-15	F	(5,420)	$7.18	-$38,916
2026-06-17	Goodnow Timothy T	Director, Officer (President and CEO)	2026-06-15	F	(32,598)	$7.18	-$234,054
2026-05-21	DeFalco Stephen P	Director	2026-05-20	A	9,852	—	$0
2026-05-21	DeFalco Stephen P	Director	2026-05-20	A	13,574	—	$0
2026-05-21	Steven Edelman	Director	2026-05-20	A	9,852	—	$0
2026-05-21	Steven Edelman	Director	2026-05-20	A	13,574	—	$0
2026-05-21	Fiorentino Edward	Director	2026-05-20	A	9,852	—	$0
2026-05-21	Fiorentino Edward	Director	2026-05-20	A	13,574	—	$0
2026-05-21	Larkin Sharon	Director	2026-05-20	A	9,852	—	$0
2026-05-21	Larkin Sharon	Director	2026-05-20	A	13,574	—	$0
2026-05-21	Prince Douglas S	Director	2026-05-20	A	9,852	—	$0
2026-05-21	Prince Douglas S	Director	2026-05-20	A	13,574	—	$0
2026-05-21	ROEDER DOUGLAS A	Director	2026-05-20	A	9,852	—	$0
2026-05-21	ROEDER DOUGLAS A	Director	2026-05-20	A	13,574	—	$0
2026-05-21	Kaufman Francine	Director, Officer (Chief Medical Officer)	2026-05-19	A	63,177	—	$0
2026-05-21	Kaufman Francine	Director, Officer (Chief Medical Officer)	2026-05-19	A	86,935	—	$0
2026-05-21	Horton Kenneth L	Officer (GC & Corp. Development Advisor)	2026-05-19	A	157,943	—	$0
2026-05-21	Horton Kenneth L	Officer (GC & Corp. Development Advisor)	2026-05-19	A	217,338	—	$0
2026-05-21	JAIN Mukul	Officer (Chief Operating Officer)	2026-05-19	A	270,759	—	$0
2026-05-21	JAIN Mukul	Officer (Chief Operating Officer)	2026-05-19	A	372,579	—	$0
2026-05-21	Sullivan Frederick T.	Officer (Chief Financial Officer)	2026-05-19	A	90,253	—	$0
2026-05-21	Sullivan Frederick T.	Officer (Chief Financial Officer)	2026-05-19	A	124,193	—	$0
2026-05-21	HANSEN BRIAN B	Director, Officer (Chief Commercial Officer)	2026-05-19	A	90,253	—	$0
2026-05-21	HANSEN BRIAN B	Director, Officer (Chief Commercial Officer)	2026-05-19	A	124,193	—	$0
2026-05-21	Goodnow Timothy T	Director, Officer (President and CEO)	2026-05-19	A	553,701	—	$0
2026-05-21	Goodnow Timothy T	Director, Officer (President and CEO)	2026-05-19	A	761,923	—	$0
2026-05-18	Sullivan Frederick T.	Officer (Chief Financial Officer)	2026-05-15	F	(9,005)	$5.82	-$52,409
2026-05-18	Kaufman Francine	Director, Officer (Chief Medical Officer)	2026-05-15	F	(6,058)	$5.82	-$35,258
2026-05-18	JAIN Mukul	Officer (Chief Operating Officer)	2026-05-15	F	(13,681)	$5.82	-$79,623
2026-05-18	Goodnow Timothy T	Director, Officer (President and CEO)	2026-05-15	F	(28,598)	$5.82	-$166,440
2026-05-18	Horton Kenneth L	Officer (GC & Corp. Development Advisor)	2026-05-15	F	(7,320)	$5.82	-$42,602
2026-05-13	ROEDER DOUGLAS A	Director	2026-05-12	P	22,686	$5.56	$126,134
2026-04-02	ROEDER DOUGLAS A	Director	2026-04-01	A	2,218	$6.65	$14,750
2026-04-02	Prince Douglas S	Director	2026-04-01	A	1,221	$6.65	$8,120
2026-04-02	Fiorentino Edward	Director	2026-04-01	A	2,124	$6.65	$14,125
2026-04-02	Steven Edelman	Director	2026-04-01	A	1,936	$6.65	$12,874
2026-03-16	ROEDER DOUGLAS A	Director	2026-03-13	P	17,500	$5.73	$100,275
2026-03-16	Goodnow Timothy T	Director, Officer (President and CEO)	2026-03-13	P	17,225	$5.79	$99,733
2026-01-05	Prince Douglas S	Director	2026-01-02	A	1,379	$5.89	$8,122
2026-01-05	ROEDER DOUGLAS A	Director	2026-01-02	A	2,504	$5.89	$14,749
2026-01-05	Fiorentino Edward	Director	2026-01-02	A	2,398	$5.89	$14,124
2026-01-05	Steven Edelman	Director	2026-01-02	A	2,185	$5.89	$12,870
2025-11-18	Sullivan Frederick T.	Officer (Chief Financial Officer)	2025-11-15	F	(6,402)	$6.26	-$40,077
2025-11-18	Kaufman Francine	Director, Officer (Chief Medical Officer)	2025-11-15	F	(4,605)	$6.26	-$28,827
2025-11-18	JAIN Mukul	Officer (Chief Operating Officer)	2025-11-15	F	(10,317)	$6.26	-$64,584
2025-11-18	Horton Kenneth L	Officer (GC & Corp. Development Advisor)	2025-11-15	F	(5,997)	$6.26	-$37,541
2025-11-18	Goodnow Timothy T	Director, Officer (President and CEO)	2025-11-15	F	(27,067)	$6.26	-$169,439
2025-11-13	Steven Edelman	Director	2025-11-10	P	10,000	$6.55	$65,500
2025-11-10	ROEDER DOUGLAS A	Director	2025-11-07	P	15,000	$5.83	$87,450
2025-11-10	Sullivan Frederick T.	Officer (Chief Financial Officer)	2025-11-07	P	5,415	$5.88	$31,840
2025-11-10	Goodnow Timothy T	Director, Officer (President and CEO)	2025-11-07	P	(17,210)	$5.87	-$101,023
2025-10-03	Prince Douglas S	Director	2025-10-01	A	19,673	$0.41	$8,125
2025-10-03	ROEDER DOUGLAS A	Director	2025-10-01	A	35,714	$0.41	$14,750
2025-10-03	Fiorentino Edward	Director	2025-10-01	A	34,200	$0.41	$14,125
2025-10-03	Steven Edelman	Director	2025-10-01	A	31,174	$0.41	$12,875
2025-07-03	Prince Douglas S	Director	2025-07-01	A	17,069	$0.48	$8,125
2025-07-03	ROEDER DOUGLAS A	Director	2025-07-01	A	30,987	$0.48	$14,750
2025-07-03	Fiorentino Edward	Director	2025-07-01	A	29,674	$0.48	$14,125
2025-07-03	Steven Edelman	Director	2025-07-01	A	27,048	$0.48	$12,875
2025-06-17	Sullivan Frederick T.	Officer (Chief Financial Officer)	2025-06-16	F	(27,263)	$0.51	-$13,904
2025-06-17	Kaufman Francine	Director, Officer (Chief Medical Officer)	2025-06-16	F	(28,853)	$0.51	-$14,715
2025-06-17	JAIN Mukul	Officer (Chief Operating Officer)	2025-06-16	F	(58,761)	$0.51	-$29,968
2025-06-17	Horton Kenneth L	Officer (GC & Corp. Development Advisor)	2025-06-16	F	(35,784)	$0.51	-$18,250
2025-06-17	Goodnow Timothy T	Director, Officer (President and CEO)	2025-06-16	F	(79,646)	$0.51	-$40,619
2025-05-29	HANSEN BRIAN B	Director	2025-05-23	A	842,084	—	$0
2025-05-29	HANSEN BRIAN B	Director	2025-05-23	A	1,187,987	—	$0
2025-05-28	Prince Douglas S	Director	2025-05-23	A	111,386	—	$0
2025-05-28	Prince Douglas S	Director	2025-05-23	A	157,234	—	$0
2025-05-28	Larkin Sharon	Director	2025-05-23	A	111,386	—	$0
2025-05-28	Larkin Sharon	Director	2025-05-23	A	157,234	—	$0
2025-05-28	Steven Edelman	Director	2025-05-23	A	111,386	—	$0
2025-05-28	Steven Edelman	Director	2025-05-23	A	157,234	—	$0
2025-05-28	DeFalco Stephen P	Director	2025-05-23	A	111,386	—	$0
2025-05-28	DeFalco Stephen P	Director	2025-05-23	A	157,234	—	$0
2025-05-28	Kaufman Francine	Director, Officer (Chief Medical Officer)	2025-05-23	A	455,716	—	$0
2025-05-28	Kaufman Francine	Director, Officer (Chief Medical Officer)	2025-05-23	A	642,911	—	$0
2025-05-28	Horton Kenneth L	Officer (GC & Corp. Development Advisor)	2025-05-23	A	505,251	—	$0
2025-05-28	Horton Kenneth L	Officer (GC & Corp. Development Advisor)	2025-05-23	A	712,792	—	$0
2025-05-28	Fiorentino Edward	Director	2025-05-23	A	111,386	—	$0
2025-05-28	Fiorentino Edward	Director	2025-05-23	A	157,234	—	$0
2025-05-28	ROEDER DOUGLAS A	Director	2025-05-23	A	111,386	—	$0
2025-05-28	ROEDER DOUGLAS A	Director	2025-05-23	A	157,234	—	$0
2025-05-28	JAIN Mukul	Officer (Chief Operating Officer)	2025-05-23	A	990,688	—	$0
2025-05-28	JAIN Mukul	Officer (Chief Operating Officer)	2025-05-23	A	1,397,632	—	$0
2025-05-28	Sullivan Frederick T.	Officer (Chief Financial Officer)	2025-05-23	A	693,481	—	$0
2025-05-28	Sullivan Frederick T.	Officer (Chief Financial Officer)	2025-05-23	A	978,342	—	$0
2025-05-28	Goodnow Timothy T	Director, Officer (President and CEO)	2025-05-23	A	2,025,956	—	$0
2025-05-28	Goodnow Timothy T	Director, Officer (President and CEO)	2025-05-23	A	2,858,157	—	$0
2025-05-19	Sullivan Frederick T.	Officer (Chief Financial Officer)	2025-05-15	F	(112,811)	$0.55	-$62,046
2025-05-19	Kaufman Francine	Director, Officer (Chief Medical Officer)	2025-05-15	F	(101,587)	$0.55	-$55,873
2025-05-19	JAIN Mukul	Officer (Chief Operating Officer)	2025-05-15	F	(260,393)	$0.55	-$143,216
2025-05-19	Horton Kenneth L	Officer (GC & Corp. Development Advisor)	2025-05-15	F	(167,085)	$0.55	-$91,897
2025-05-19	Goodnow Timothy T	Director, Officer (President and CEO)	2025-05-15	F	(379,164)	$0.55	-$208,540
2025-04-03	Fiorentino Edward	Director	2025-04-01	A	21,243	$0.66	$14,124
2025-04-03	Prince Douglas S	Director	2025-04-01	A	12,219	$0.66	$8,124
2025-04-03	Steven Edelman	Director	2025-04-01	A	19,363	$0.66	$12,874
2025-04-03	ROEDER DOUGLAS A	Director	2025-04-01	A	22,183	$0.66	$14,749
2025-01-03	ROEDER DOUGLAS A	Director	2025-01-02	A	31,183	$0.47	$14,750
2025-01-03	Fiorentino Edward	Director	2025-01-02	A	29,862	$0.47	$14,125
2025-01-03	Prince Douglas S	Director	2025-01-02	A	17,177	$0.47	$8,125
2025-01-03	Steven Edelman	Director	2025-01-02	A	27,219	$0.47	$12,875
2024-12-20	ROEDER DOUGLAS A	Director	2024-12-13	P	75,000	$0.50	$37,500
2024-12-16	ROEDER DOUGLAS A	Director	2024-12-13	P	25,000	$0.50	$12,500
2024-12-16	ROEDER DOUGLAS A	Director	2024-12-12	P	300,000	$0.41	$123,000
2024-12-12	Sullivan Frederick T.	Officer (Chief Financial Officer)	2024-12-12	P	124,933	$0.38	$47,475
2024-12-10	Goodnow Timothy T	Director, Officer (President and CEO)	2024-12-10	P	315,000	$0.31	$97,650
2024-11-18	Sullivan Frederick T.	Officer (Chief Financial Officer)	2024-11-15	F	(181,627)	$0.28	-$50,856
2024-11-18	Kaufman Francine	Director, Officer (Chief Medical Officer)	2024-11-15	F	(118,645)	$0.28	-$33,221
2024-11-18	JAIN Mukul	Officer (Chief Operating Officer)	2024-11-15	F	(282,546)	$0.28	-$79,113
2024-11-18	Horton Kenneth L	Officer (GC & Corp. Development Advisor)	2024-11-15	F	(187,665)	$0.28	-$52,546
2024-11-18	Goodnow Timothy T	Director, Officer (President and CEO)	2024-11-15	F	(632,166)	$0.28	-$177,006
2024-10-02	Steven Edelman	Director	2024-10-01	A	38,193	$0.34	$12,875
2024-10-02	Fiorentino Edward	Director	2024-10-01	A	41,901	$0.34	$14,125
2024-10-02	ROEDER DOUGLAS A	Director	2024-10-01	A	43,755	$0.34	$14,750
2024-10-02	Prince Douglas S	Director	2024-10-01	A	24,102	$0.34	$8,125